VTU Group appoints Liam O'Neil as new CEO

31-Jul-2025
© VTU

Liam O'Neil, CEO of the VTU Group

VTU Group announces the appointment of Liam O'Neil as its new Chief Executive Officer (CEO). He succeeds long-serving CEO Friedrich Fröschl, who will move to an advisory role at the end of 2025.

Liam O'Neil brings extensive experience and a proven track record in engineering services and project management. With over 23 years' experience in the energy sector, he has held various senior roles in private and public companies, including Chief Operating Officer of private equity-led engineering and construction company PD&MS Group and most recently President of Growth and Execution at Wood. There he led key areas in new energies, process and chemical engineering, life sciences, minerals and metals.

Born in Scotland and raised in Canada and the UK, Liam O'Neil began his career in technical roles in automation, controls and instrumentation. In addition to his recent roles, he has also worked for several large listed companies on both the client and contractor side - including Petrofac, AMEC Foster Wheeler and Worley. Liam has held a variety of technical, project and management roles and has successfully led numerous modification projects and major projects. He has also driven organic growth with blue chip clients.

Liam holds an MBA from the University of Warwick, an MSc in Project Management and postgraduate degrees in Civil Engineering and Management. He completed executive programs at the Saïd Business School at the University of Oxford and is currently completing an MSc in Finance at the University of Manchester.

With his broad expertise and commitment to excellence, he is ideally equipped to lead the VTU Group into a successful future.

Friedrich Fröschl commented: "In Liam O'Neil we have found a highly experienced engineering manager whose background in engineering and project management as well as his professional development have equipped him with the ideal skills profile to continue VTU's success story. It will be a pleasure to support him as he takes on the CEO role and I wish him all the best in his new leadership role at VTU Group."

Liam O'Neil expressed his excitement about his new role: "I am very honored to be joining VTU as CEO at such a pivotal time in the company's development. VTU stands for technical excellence, trusted, long-term customer relationships and a strong, people-centered culture - all of which I want to preserve and build on.

My first impression is that we have a highly skilled and motivated workforce ready to support our customers in a complex and changing environment. VTU is a trustworthy and adaptable partner - with a focus on delivering what our customers really need, not just what we want to offer. This customer-centric mindset, combined with our technical depth and flexibility, makes us unique.

To serve our customers even better, we will scale responsibly: Improve systems, strengthen implementation and introduce new capabilities - without losing what makes VTU special.

Growth and professionalization must go hand in hand with our culture. I am determined to lead VTU into the next chapter of success, staying true to the values and spirit that got us here. I look forward to listening, learning and working closely with our great teams across Europe to shape the future of VTU together."

Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of current news. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.

Other news from the department people

Most read news

More news from our other portals

So close that even
molecules turn red...

Last viewed contents

Bayer extends partnership with Tsinghua University to accelerate pharmaceutical research in China - Extended collaboration underscores Bayer's commitment and growth strategy in innovation in China and globally

Bayer extends partnership with Tsinghua University to accelerate pharmaceutical research in China - Extended collaboration underscores Bayer's commitment and growth strategy in innovation in China and globally

Intelligent wound dressing controls inflammation - ETH start-up is developing a granular hydrogel that selectively captures inflammatory signals from chronic wounds while also actively promoting healing

Intelligent wound dressing controls inflammation - ETH start-up is developing a granular hydrogel that selectively captures inflammatory signals from chronic wounds while also actively promoting healing

Ready and running – WACKER Biotechnology Center in Munich - The focus will be on research in manufacturing processes for biopharmaceuticals and ingredients for food and dietary supplements

Ready and running – WACKER Biotechnology Center in Munich - The focus will be on research in manufacturing processes for biopharmaceuticals and ingredients for food and dietary supplements

Merck and Washington University in St. Louis Sign MoU to Advance Scientific Collaboration - Strategic academic-industry alliance aims to build robust Research & Development talent pipeline

Merck and Washington University in St. Louis Sign MoU to Advance Scientific Collaboration - Strategic academic-industry alliance aims to build robust Research & Development talent pipeline

WACKER and start-up Gearbox Biosciences announce strategic collaboration - The partnership aims to co-develop technologies set to revolutionize manufacturing of plasmid DNA (pDNA)

WACKER and start-up Gearbox Biosciences announce strategic collaboration - The partnership aims to co-develop technologies set to revolutionize manufacturing of plasmid DNA (pDNA)

Cannovum Health welcomes new strategic majority investor

Cannovum Health welcomes new strategic majority investor

Dr. Wolf-Henning Walther becomes new CEO at Metrohm Germany - Change in the Executive Board from September 1, 2025

Dr. Wolf-Henning Walther becomes new CEO at Metrohm Germany - Change in the Executive Board from September 1, 2025

Norgine completes acquisition of Theravia

Norgine completes acquisition of Theravia

New method loads mRNA into exosomes in 10 minutes—just mix and go - KIST team develops cubosome-based method for loading large therapeutics without damaging exosomes

New method loads mRNA into exosomes in 10 minutes—just mix and go - KIST team develops cubosome-based method for loading large therapeutics without damaging exosomes

Reduced genome – flexible performance: How symbiotic bacteria with minimal genetic information support their host - Despite having only a tiny genome, the symbionts of reed beetles can adapt their gene activity flexibly to the developmental stages and ambient temperatures of their hosts

Reduced genome – flexible performance: How symbiotic bacteria with minimal genetic information support their host - Despite having only a tiny genome, the symbionts of reed beetles can adapt their gene activity flexibly to the developmental stages and ambient temperatures of their hosts

Insights into olfactory disorders in Alzheimer's disease

Insights into olfactory disorders in Alzheimer's disease

Ultrasound could deliver drugs with fewer side effects

Ultrasound could deliver drugs with fewer side effects